LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    Joint Statement on the EC Initiative: Boosting Biotechnology and Biomanufacturing in the EU

    25/04/2024
    POSITION PAPER

    Brussels, 25 April 2024

     

    The European Commission Initiative Boosting Biotechnology and Biomanufacturing in the EU  is welcomed by Industry associations and organisations working to innovate, apply and scale biotechnology and biomanufacturing within multiple sectors.

    Action for biotechnology and biomanufacturing is of critical importance across industrial and research ecosystems as they respond to future needs. It is integral to the EU’s strategic objectives, strengthening a globally competitive and resilient economy through industrial innovation, and is a key contributor to the sustainability transition, health security and economic growth.

    The Initiative is a positive starting point for greater ambition and implementation for biotechnology and biomanufacturing as a recognised critical technology for economic security, whilst positioning the EU as a global innovation actor. It reflects the universal applications of biotechnology and its role as an enabler for industrial and societal transition. The Initiative also recognises challenges and barriers, including the need for a level-playing field for market entry and demand, plus protection and incentivisation for innovation.

    Whilst we welcome a potential future EU Biotech Act, ambitious and urgent actions are needed today to address bottlenecks that currently hinder investment into innovation, scale up and commercialisation. These immediate actions for biotechnology and biomanufacturing include:

    • streamline and align regulatory pathways
    • ensure access to feedstocks for biomanufacturing
    • reflect financing of innovation and scale up, including within EU taxonomy
    • improve public understanding and recognition of biotech within a strong future Europe

    We urge the incoming European Commission to ensure legislative and financial commitments for this Initiative. Implementation should be driven by a multi-Directorate approach with high-level leadership and consistency of policy approach. We also call for EU Member States to take ownership of the Initiative at national level and align actions, and for the European Parliament to reflect Initiative outcomes within legislative action.

    We affirm our commitment to work in partnership with policymakers and all stakeholders to ensure the EU delivers on its objectives, with ambition for global competitiveness and leadership in biotechnology and biomanufacturing.

    Signatories include Alliance for Biosolutions,  Association of Manufacturers and Formulators of Enzyme Products (AMFEP), Bio-Based Industries Consortium (BIC), BioChem Europe, Cellular Agriculture Europe, Confederation of European Yeast Producers (COFALEC), CropLife Europe, EFPIA,  European Biodiesel Board (EBB), European Bioplastics, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), European Food and Fermentation Cultures Association (EFFCA), Euroseeds, EU Association of Specialty Feed Ingredients and their Mixtures (FEFANA), EuropaBio, Food Fermentation Europe, Good Food Institute Europe and IPA Europe.

    Joint Statement on the EC Initiative: Boosting Biotechnology and Biomanufacturing in the EU


    Download

    Share
    Adrian Lincoln
    Adrian Lincoln

    Related posts

    03/02/2026

    Ecolab Life Sciences joins EuropaBio: Helping Shape the Future of Life Sciences Manufacturing in Europe


    Read more
    29/01/2026

    EuropaBio Consultation Response: Public Procurement Directives


    Read more
    23/01/2026

    Germany: Industrial Bioeconomy Dialogue Platform of the Federal Ministry for Economic Affairs and Energy (BMWE), Position paper on amending the European GMO legal framework for microorganisms.


    Read more

    Important links

    • OECD: A comparison of the innovation and regulatory environments for biotechnology and biosolutions across the European Union and the United States
    • Ecolab Life Sciences joins EuropaBio: Helping Shape the Future of Life Sciences Manufacturing in Europe

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.